For the first one, this one is orange
The American Diabetes Association (ADA) recommends considering periodic measurement of vitamin B12 levels in patients with type 2 diabetes taking metformin, particularly those with anemia or peripheral neuropathy, though no specific monitoring interval is specified
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
Group 3 received 0.25 mg of AOD9604 per 0.6 mL injection, and Group 4 received a combination of AOD9604 at 0.25 mg and HA at 6 mg
I have found that a stiffer starter, or one with less water to total flour, can handle the cold temperatures of the refrigerator a little better than those with 100% hydration
Subcutaneous injection produces a slower absorption phase that can extend the apparent terminal half-life